Download your free research report from Scrip, presented in partnership with PCI Pharma Services.

With biologics an established and still-growing cornerstone of the industry, accounting for 30% of all prescription and over-the-counter sales in 2020, the need for high-quality clinical trial and commercial services is greater than ever.

PCI Pharma Services and Pharma Intelligence polled decision makers at leading biologics companies to understand how the industry is approaching outsourcing today and how they are likely to use outsourcing in the future. Tap into these findings in your illuminating free research report, ““Biologics Outsourcing is Increasing. What Does that Mean for the Biopharma Industry?”